74 related articles for article (PubMed ID: 11144149)
1. [A new turn of research for morphine dependence].
Narita M; Yajima Y; Suzuki T
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2000 Oct; 35(5):283-94. PubMed ID: 11144149
[TBL] [Abstract][Full Text] [Related]
2. Locus-specific involvement of anti-opioid systems in morphine tolerance and dependence.
Ueda H
Ann N Y Acad Sci; 2004 Oct; 1025():376-82. PubMed ID: 15542739
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of opioid dependence and interaction between opioid receptors.
Suzuki T; Kishimoto Y; Ozaki S; Narita M
Eur J Pain; 2001; 5 Suppl A():63-5. PubMed ID: 11798220
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of neurogranin, protein kinase C, and Ca2+/calmodulin dependent protein kinase II in opioid tolerance and dependence.
Shukla PK; Tang L; Wang ZJ
Neurosci Lett; 2006 Sep; 404(3):266-9. PubMed ID: 16824682
[TBL] [Abstract][Full Text] [Related]
5. Chronic morphine-induced loss of the facilitative interaction between vasoactive intestinal polypeptide and delta-opioid: involvement of protein kinase C and phospholipase Cbetas.
Liu NJ; Chakrabarti S; Gintzler AR
Brain Res; 2004 Jun; 1010(1-2):1-9. PubMed ID: 15126111
[TBL] [Abstract][Full Text] [Related]
6. mu-Opioid receptor internalization-dependent and -independent mechanisms of the development of tolerance to mu-opioid receptor agonists: Comparison between etorphine and morphine.
Narita M; Suzuki M; Narita M; Niikura K; Nakamura A; Miyatake M; Yajima Y; Suzuki T
Neuroscience; 2006; 138(2):609-19. PubMed ID: 16417975
[TBL] [Abstract][Full Text] [Related]
7. How important is protein kinase C in mu-opioid receptor desensitization and morphine tolerance?
Bailey CP; Smith FL; Kelly E; Dewey WL; Henderson G
Trends Pharmacol Sci; 2006 Nov; 27(11):558-65. PubMed ID: 17000011
[TBL] [Abstract][Full Text] [Related]
8. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
9. Role of G(i)alpha2-protein in opioid tolerance and mu-opioid receptor downregulation in vivo.
Yoburn BC; Gomes BA; Rajashekara V; Patel C; Patel M
Synapse; 2003 Feb; 47(2):109-16. PubMed ID: 12454948
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of mitogen-activated protein kinase kinases (MEK1/2) by mu-, delta- and kappa-opioid receptor agonists in the rat brain: regulation by chronic morphine and opioid withdrawal.
Asensio VJ; Miralles A; García-Sevilla JA
Eur J Pharmacol; 2006 Jun; 539(1-2):49-56. PubMed ID: 16678156
[TBL] [Abstract][Full Text] [Related]
11. Involvement of kappa opioid receptors in the inhibition of receptor desensitization and PKC activation induced by repeated morphine treatment.
Hamabe W; Yamane H; Harada S; Tokuyama S
J Pharm Pharmacol; 2008 Sep; 60(9):1183-8. PubMed ID: 18718122
[TBL] [Abstract][Full Text] [Related]
12. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
[TBL] [Abstract][Full Text] [Related]
13. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors.
Khotib J; Narita M; Suzuki M; Yajima Y; Suzuki T
Neuropharmacology; 2004 Mar; 46(4):531-40. PubMed ID: 14975677
[TBL] [Abstract][Full Text] [Related]
14. Neurofilament proteins and cAMP pathway in brains of mu-, delta- or kappa-opioid receptor gene knock-out mice: effects of chronic morphine administration.
García-Sevilla JA; Ferrer-Alcón M; Martín M; Kieffer BL; Maldonado R
Neuropharmacology; 2004 Mar; 46(4):519-30. PubMed ID: 14975676
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C activation enhances morphine-induced rapid desensitization of mu-opioid receptors in mature rat locus ceruleus neurons.
Bailey CP; Kelly E; Henderson G
Mol Pharmacol; 2004 Dec; 66(6):1592-8. PubMed ID: 15361548
[TBL] [Abstract][Full Text] [Related]
16. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
17. Reversal of morphine antinociceptive tolerance and dependence by the acute supraspinal inhibition of Ca(2+)/calmodulin-dependent protein kinase II.
Tang L; Shukla PK; Wang LX; Wang ZJ
J Pharmacol Exp Ther; 2006 May; 317(2):901-9. PubMed ID: 16505162
[TBL] [Abstract][Full Text] [Related]
18. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
19. Evidence of involvement of the nNOS and the kappa-opioid receptor in the same intracellular network of the rat periaqueductal gray that controls morphine tolerance and dependence.
Herráez-Baranda LA; Carretero J; González-Sarmiento R; Laorden ML; Milanés MV; Rodríguez RE
Brain Res Mol Brain Res; 2005 Jun; 137(1-2):166-73. PubMed ID: 15950775
[TBL] [Abstract][Full Text] [Related]
20. [Molecular mechanism of morphine tolerance and biological approaches to resolve tolerance].
Nishikawa K; Tanobe K; Hinohara H; Okamoto T; Saito S; Goto F
Masui; 2004 May; 53(5):502-7. PubMed ID: 15198232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
